Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library First-Trimester Screening for Birth Defects

First-Trimester Screening for Birth Defects

Test Overview

During the first trimester of pregnancy, screening tests for birth defects may be done. These tests look for possible problems with your baby. The tests may be called first-trimester screening, combined first-trimester screening, or the combined screening.

The screening tests show the chance of your baby having certain birth defects such as Down syndrome or trisomy 18.

First-trimester screening tests include:

Blood tests.

These measure the level of two substances in the blood called pregnancy-associated plasma protein A (PAPP-A) and beta-human chorionic gonadotropin hormone (beta-hCG). PAPP-A is a protein in the blood. Beta-hCG is a hormone made by the placenta.

Nuchal translucency test.
This test uses ultrasound to measure the thickness of the skin at the back of your baby's neck. An increase in the thickness can be an early sign of Down syndrome.

In some cases, the doctors look at the combined screenings that you've had over a period of time. This is called an integrated screening. It's done in two stages at two different times during the pregnancy.

How It Is Done

How It Is Done

Screening tests for birth defects done in the first trimester of pregnancy can be done using a sample of your blood and using ultrasound to measure the thickness of the skin at the back of your baby's neck.

Blood tests

A health professional uses a needle to take a blood sample, usually from the arm.

Nuchal translucency ultrasound test

A small, handheld device is moved over your belly to display images of the baby. The thickness of the fluid buildup at the back of the baby's neck is measured.

Results

Results

First-trimester screening shows the chance of your baby having certain birth defects such as Down syndrome or trisomy 18.

Your doctor may tell you the result of your test as a set of numbers.

  • A positive result means that there is a higher-than-average chance that your baby has Down syndrome or trisomy 18. Doctors often use a certain number as a cutoff for a positive result. For example, your doctor may say the cutoff is 1 out of 200. This means that if your result is 1 out of 200 or 1 out of a number less than 200 (such as 1 out of 100), you have a positive result. This means that your baby has a higher chance of a birth defect.
  • A negative result means that your baby probably doesn't have those birth defects. If your result is 1 out of 300, this means that you have a negative result and your baby has a lower chance of a birth defect. But it doesn't guarantee that you will have a normal pregnancy or baby.

If you have a positive test result, your doctor may give you the option to have chorionic villus sampling (CVS) or an amniocentesis test in the second trimester to find out if your baby has a problem. But it's your choice whether to have another test.

If you have a negative result, you may choose not to have any more tests.

Accuracy of the test

First-trimester screening (nuchal translucency combined with blood tests) correctly finds Down syndrome in 82 to 87 out of 100 fetuses who have it. This also means that these tests miss it in 13 to 18 out of 100 fetuses.footnote 1

It's possible that a screening test will be positive—meaning the test result is abnormal—but the baby doesn't have the problem. This is called a false-positive test result. And it's also possible that a screening may show that a baby doesn't have a birth defect when he or she does have it. This is called a false-negative test result.

A false-positive result can cause stress and lead to testing you don't need (such as chorionic villus sampling [CVS]). Many women who have a positive screening test result are actually carrying a healthy baby.

References

References

Citations

  1. American College of Obstetricians and Gynecologists (2016). Screening for fetal aneuploidy. ACOG Practice Bulletin No. 163. Obstetrics and Gynecology, 127(5): e123–e137. DOI: 10.1097/AOG.0000000000001406. Accessed April 6, 2017.

Current as of: April 30, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

© 2024 Ignite Healthwise, LLC. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Ignite Healthwise, LLC.

Related Links

Second-Trimester Exams and Tests Birth Defects Testing

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About Cigna Healthcare Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details